Matches in Wikidata for { <http://www.wikidata.org/entity/Q84968455> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q84968455 description "article scientifique publié en 2012" @default.
- Q84968455 description "artículu científicu espublizáu n'ochobre de 2012" @default.
- Q84968455 description "im Oktober 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q84968455 description "scientific article published on 01 October 2012" @default.
- Q84968455 description "wetenschappelijk artikel" @default.
- Q84968455 description "наукова стаття, опублікована в жовтні 2012" @default.
- Q84968455 name "Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension" @default.
- Q84968455 name "Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension" @default.
- Q84968455 type Item @default.
- Q84968455 label "Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension" @default.
- Q84968455 label "Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension" @default.
- Q84968455 prefLabel "Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension" @default.
- Q84968455 prefLabel "Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension" @default.
- Q84968455 P1433 Q84968455-7C0DA9E2-F195-4D5B-84A9-EB9587A3D42F @default.
- Q84968455 P1476 Q84968455-4F3CD6A2-3B23-48B8-A376-5B84B50381BD @default.
- Q84968455 P2093 Q84968455-035D4847-6A5E-4D29-BA35-5187A3812391 @default.
- Q84968455 P2093 Q84968455-3DFCD147-5292-4160-B4E8-CF8A248455E0 @default.
- Q84968455 P2093 Q84968455-708AA9D9-CC4B-4892-90A0-5F60A4762276 @default.
- Q84968455 P2093 Q84968455-728849A0-185F-4952-9F80-BD67D5A497C2 @default.
- Q84968455 P2093 Q84968455-73A5F13E-8AD9-4411-99D1-D8FF9B539FD9 @default.
- Q84968455 P2093 Q84968455-8D8B5041-25C9-4BEF-B481-1CF9D50506C9 @default.
- Q84968455 P304 Q84968455-0253BC11-A988-4FB9-894A-7415BCF21399 @default.
- Q84968455 P31 Q84968455-ED1AB9A8-4F33-4840-9B1C-9E00D5AE9A92 @default.
- Q84968455 P356 Q84968455-47B91AAE-C587-4595-A840-FB5570D04730 @default.
- Q84968455 P433 Q84968455-B9B3D8BD-8B84-4701-892B-30553F601002 @default.
- Q84968455 P478 Q84968455-C603A227-4A3C-48EB-B6FD-E7FC8D035152 @default.
- Q84968455 P50 Q84968455-8BFCBDA8-5C4B-4A5B-B8F3-78CAC7E3C0A4 @default.
- Q84968455 P577 Q84968455-58461748-93E0-47AB-82EF-6BBDEBF34C58 @default.
- Q84968455 P698 Q84968455-E213A703-7B02-4109-97B5-0B762FA07D9C @default.
- Q84968455 P921 Q84968455-106E15B3-51B4-47D9-8DFE-558F519EB417 @default.
- Q84968455 P921 Q84968455-122F911F-3916-43ED-8AF0-E1356A5A1551 @default.
- Q84968455 P921 Q84968455-668D97F5-4BCE-4236-9D87-2122BD0B6FE5 @default.
- Q84968455 P921 Q84968455-87424845-6741-4879-9946-B5EB74BCE92D @default.
- Q84968455 P921 Q84968455-A3DE07D2-C6C3-43AB-8000-F4DECBAC2DA0 @default.
- Q84968455 P356 DOM.12011 @default.
- Q84968455 P698 22974280 @default.
- Q84968455 P1433 Q5270109 @default.
- Q84968455 P1476 "Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension" @default.
- Q84968455 P2093 "A H Barnett" @default.
- Q84968455 P2093 "H-J Woerle" @default.
- Q84968455 P2093 "R Harper" @default.
- Q84968455 P2093 "R Toorawa" @default.
- Q84968455 P2093 "S Patel" @default.
- Q84968455 P2093 "S Thiemann" @default.
- Q84968455 P304 "1145-1154" @default.
- Q84968455 P31 Q13442814 @default.
- Q84968455 P356 "10.1111/DOM.12011" @default.
- Q84968455 P433 "12" @default.
- Q84968455 P478 "14" @default.
- Q84968455 P50 Q51731857 @default.
- Q84968455 P577 "2012-10-01T00:00:00Z" @default.
- Q84968455 P698 "22974280" @default.
- Q84968455 P921 Q19484 @default.
- Q84968455 P921 Q269829 @default.
- Q84968455 P921 Q3025883 @default.
- Q84968455 P921 Q42824827 @default.
- Q84968455 P921 Q909745 @default.